NewAmsterdam Pharma Growth Metrics (2022-2026) | NAMS

Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -0.62M0.05M0.15M0.54M0.54M0.16M-2.05M-23.29M-0.03M
EBITDA Margin Growth (3y) (Quarter) -0.11M
EBITDA Margin (QoQ) (Quarter) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.05M-21.31M23.20M
EBIT Margin Growth (1y) (Quarter) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M-20.58M0.04M
EBIT Margin Growth (3y) (Quarter) -0.15M
EBIT Margin (QoQ) (Quarter) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M-19.03M20.43M
EBT Margin Growth (1y) (Quarter) -0.62M0.05M0.15M0.65M0.54M0.16M-2.06M-23.45M-0.03M
EBT Margin Growth (3y) (Quarter) -0.11M
EBT Margin (QoQ) (Quarter) -0.17M0.06M-0.46M-0.05M0.50M0.17M0.04M-0.17M0.12M-2.06M-21.34M23.25M
Enterprise Value Growth (1y) (Quarter) -636.64%23.90%-9.03%9.80%-14.78%-145.03%-68.03%-71.62%-66.29%41.10%43.23%
Enterprise Value Growth (3y) (Quarter) -139.48%-3.17%-1.31%
Enterprise Value (QoQ) (Quarter) 1.36%-8.20%22.87%7.56%-41.33%10.48%1.85%-97.33%3.08%8.57%4.90%30.11%6.59%
FCF Margin Growth (1y) (Quarter) -0.36M0.16M0.38M0.27M0.22M-0.94M-12.78M0.02M
FCF Margin Growth (3y) (Quarter) -0.06M
FCF Margin (QoQ) (Quarter) -0.25M0.02M0.15M0.23M-0.03M-0.09M0.10M-0.92M-11.86M12.70M
Net Margin Growth (1y) (Quarter) -0.62M0.15M0.65M0.54M0.16M-2.06M-23.45M-0.03M
Net Margin Growth (3y) (Quarter) -0.11M
Net Margin (QoQ) (Quarter) -0.46M-0.05M0.50M0.17M0.04M-0.17M0.12M-2.06M-21.34M23.25M
Operating Margin Growth (1y) (Quarter) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M-20.58M0.04M
Operating Margin Growth (3y) (Quarter) -0.15M
Operating Margin (QoQ) (Quarter) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M-19.03M20.43M
Return on Assets Growth (1y) (Quarter) 0.00M0.00M0.00M0.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) 0.00M0.00M0.00M-26.00-778.00
Return on Capital Employed (QoQ) (Quarter) 604.00358.000.00M865.00155.00-519.00-528.00113.00
Return on Equity Growth (1y) (Quarter) 0.00M0.00M0.00M0.00M1.000.00M0.00M0.00M
Return on Equity (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Sales Growth (1y) (Quarter) -62.0015.0065.0054.0016.00-206.00-0.00M-3.00
Return on Sales Growth (3y) (Quarter) -11.00
Return on Sales (QoQ) (Quarter) -46.00-5.0050.0017.004.00-17.0012.00-206.00-0.00M0.00M